Relationship between the expression level of HER-2 and the prognosis of patients with gastric cancer in the same pathological stage
Mao-rong Liu, Shuliang Li, Xukun Li, Hengling Gao, Bo Zhang
Abstract
Mao-rong Liu, Shuliang Li, Xukun Li, Hengling Gao, Bo Zhang
Abstract
Objective To study the expression level of HER-2 gene in the same pathological stage gastric cancer,and discuss the feasibility of HER-2 gene being the prognostic indicator.Methods The expression of HER-2 in gastric cancer was detected by immunohistocehmical technique and analyzed in relation with the pathological stage and prognosis of the patients.Results The total positive rate of HER-2 in gastric cancer was 33.64% (37/110).In stage Ⅱ,the weakly and strongly positive rates of gastric cancer were 21.31% ( 13/61 ) and 9.84% (6/61).In stage Ⅲ,the weakly and strongly positive rates of gastric cancer were 20.41% (10/49) and 16.33% (8/49).In the same pathological stage,the survival rate of patients with negative HER-2 expression was higher than weakly positive ones.And the survival rate of patients with strongly positive HER-2 expression was the lowest.The difference had statistical significance (P < 0.01).Conclusion The prognosis of patients in the same stage was correlated with the expression level of HER-2,which can be used to evaluate the biological behavior and prognosis of gastric cancer. Key words: Stomach neoplasms; Pathology; Neoplasm staging; Prognosis; HER-2
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the expression level of HER-2 gene in the same pathological stage gastric cancer,and discuss the feasibility of HER-2 gene being the prognostic indicator.Methods The expression of HER-2 in gastric cancer was detected by immunohistocehmical technique and analyzed in relation with the pathological stage and prognosis of the patients.Results The total positive rate of HER-2 in gastric cancer was 33.64% (37/110).In stage Ⅱ,the weakly and strongly positive rates of gastric cancer were 21.31% ( 13/61 ) and 9.84% (6/61).In stage Ⅲ,the weakly and strongly positive rates of gastric cancer were 20.41% (10/49) and 16.33% (8/49).In the same pathological stage,the survival rate of patients with negative HER-2 expression was higher than weakly positive ones.And the survival rate of patients with strongly positive HER-2 expression was the lowest.The difference had statistical significance (P < 0.01).Conclusion The prognosis of patients in the same stage was correlated with the expression level of HER-2,which can be used to evaluate the biological behavior and prognosis of gastric cancer. Key words: Stomach neoplasms; Pathology; Neoplasm staging; Prognosis; HER-2
Key concepts: Pathological, Cancer, Stage (stratigraphy), Medicine, Internal medicine, Gastroenterology, Stomach, Survival rate